12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga · 1d ago
Gainers
- Plus Therapeutics (NASDAQ:PSTV) shares increased by 87.2% to $0.35 during Wednesday's pre-market session. The company's market cap stands at $1.1 million.
- Portage Biotech (NASDAQ:PRTG) stock increased by 22.67% to $6.6. The market value of their outstanding shares is at $12.2 million.
- AEON Biopharma (AMEX:AEON) shares increased by 17.13% to $0.83. The company's market cap stands at $8.0 million.
- Liminatus Pharma (NASDAQ:LIMN) shares increased by 17.13% to $31.24. The company's market cap stands at $693.8 million.
- BioXcel Therapeutics (NASDAQ:BTAI) stock increased by 16.76% to $2.02. The company's market cap stands at $10.4 million.
- Precision BioSciences (NASDAQ:DTIL) shares increased by 16.01% to $5.3. The market value of their outstanding shares is at $50.6 million.
Losers
- OneMedNet (NASDAQ:ONMD) stock fell 11.7% to $0.6 during Wednesday's pre-market session. The market value of their outstanding shares is at $20.8 million.
- Forte Biosciences (NASDAQ:FBRX) stock decreased by 11.01% to $12.61. The company's market cap stands at $93.2 million.
- Trinity Biotech (NASDAQ:TRIB) stock declined by 10.4% to $0.63. The market value of their outstanding shares is at $13.4 million.
- InspireMD (NASDAQ:NSPR) stock declined by 10.31% to $2.22. The company's market cap stands at $75.8 million.
- XTL Biopharmaceuticals (NASDAQ:XTLB) stock declined by 9.17% to $1.19. The market value of their outstanding shares is at $11.5 million.
- Vor Biopharma (NASDAQ:VOR) shares fell 7.99% to $0.29. The company's market cap stands at $39.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.